Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Conversion of 6,840,213 APMD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Apnimed, Inc. (APMD) | Conversion | 6,840,213 | n/a |
| Aug 17, 2023 | Kezar Life Sciences, Inc. (KZR) | Gift | 3,500,000 | n/a |
| Aug 17, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift | 2,000,000 | n/a |
| Mar 31, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 29,048 | $884.5K |
| Mar 29, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 32,964 | $997.2K |
| Mar 23, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 34,641 | $1.10M |
| Mar 17, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 9,122 | $296.9K |
| Mar 16, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 70,714 | $2.44M |
| Mar 6, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 50,000 | $1.69M |
| Feb 28, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 47,888 | $1.66M |